Cargando…
Pan-caspase inhibitor F573 mitigates liver ischemia reperfusion injury in a murine model
BACKGROUND: Liver ischemia reperfusion injury (IRI) remains a challenge in liver transplantation. A number of compounds have previously demonstrated efficacy in mitigating IRI. Herein, we applied three specific additive strategies to a mouse IRI screening model to determine their relative potencies...
Autores principales: | Bral, Mariusz, Pawlick, Rena, Marfil-Garza, Braulio, Dadheech, Nidheesh, Hefler, Joshua, Thiesen, Aducio, Shapiro, A. M. James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879152/ https://www.ncbi.nlm.nih.gov/pubmed/31770375 http://dx.doi.org/10.1371/journal.pone.0224567 |
Ejemplares similares
-
AT7867 promotes pancreatic progenitor differentiation of human iPSCs
por: Cuesta-Gomez, Nerea, et al.
Publicado: (2023) -
Preclinical systematic review & meta-analysis of cyclosporine for the treatment of myocardial ischemia-reperfusion injury
por: Hefler, Joshua, et al.
Publicado: (2022) -
Suspension culture improves iPSC expansion and pluripotency phenotype
por: Cuesta-Gomez, Nerea, et al.
Publicado: (2023) -
Inducible Pluripotent Stem Cells as a Potential Cure for Diabetes
por: Verhoeff, Kevin, et al.
Publicado: (2021) -
The Current Status of Allogenic Islet Cell Transplantation
por: Czarnecka, Zofia, et al.
Publicado: (2023)